800-799-2234
Office Locations
Mon - Fri 09:00 am - 05:00 pm
West Virginia's #1
Mesothelioma Law Firm
We Have Won
Thousands of Cases
Trusted By
10,000+ Clients
Immediate Assistance 24/7

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

Condition: Advanced Solid Tumors Cancer NCT Number: NCT03071757 Estimated Enrollment: 170 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: M16-074|2016-004205-14 Study First Received: March 7, 2017 Last Updated: August 2,...
Read More
Condition: Advanced Malignancies|Metastatic Cancer NCT Number: NCT03126110 Estimated Enrollment: 145 Phases: Phase 1|Phase 2 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: INCAGN 1876-201 Study First Received: April 24, 2017 Last Updated: May...
Read More
Condition: Advanced Solid Tumors NCT Number: NCT03000257 Estimated Enrollment: 182 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: M15-891|2016-002520-89 Study First Received: December 22, 2016 Last Updated: May 4, 2021...
Read More
Condition: Locally Advanced or Metastatic Solid Tumor NCT Number: NCT03717415 Estimated Enrollment: 117 Phases: Phase 1|Phase 2 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: DCC-2036-01-004 Study First Received: October 24, 2018 Last...
Read More
Condition: Cancer NCT Number: NCT03926143 Estimated Enrollment: 9 Phases: Phase 2 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: 20322|2019-000061-20 Study First Received: April 24, 2019 Last Updated: October 12, 2021 Estimated Primary...
Read More
Condition: Advanced Solid Tumors (Part A/B/C/D)|Non-small Cell Lung Cancer (Part E)|Melanoma (Part E)|Squamous Cell Cancer of the Head and Neck (Part E)|Triple Negative Breast Cancer (Part F)|Adrenocortical Carcinoma (Part G)|Mesothelioma (Part G)|High-circulating Myeloid-derived Suppressor Cells (Part H) NCT Number: NCT02637531 Estimated Enrollment: 219 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older...
Read More
Condition: Diffuse Large B-cell Lymphoma (DLBCL)|Follicular Lymphoma (FL)|Synovial Sarcoma|Epitheliod Sarcoma (ES)|Mesothelioma|Advanced Solid Tumors|Renal Medullary Carcinoma|Non-Hodgkin Lymphoma (NHL) NCT Number: NCT02875548 Estimated Enrollment: 100 Phases: Phase 2 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID...
Read More
Condition: Metastatic Cancer|Solid Tumors|Colorectal Cancer (CRC)|Gastric Cancer|Head and Neck Cancer|Lung Cancer|Renal Cell Carcinoma (RCC)|Bladder Cancer|UC (Urothelial Cancer)|Mesothelioma NCT Number: NCT02903914 Estimated Enrollment: 260 Phases: Phase 1|Phase 2 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: Has Results Study Design Allocation: Allocation: Has Results Study ID Numbers:...
Read More
Condition: Cervical Cancer|Gastric Cancer|Stomach Cancer|Gastroesophageal Junction Cancer|Esophageal Cancer|Hepatocellular Carcinoma|Melanoma|Uveal Melanoma|Merkel Cell Carcinoma|Mesothelioma|MSI|Non-small Cell Lung Cancer|NSCLC|Ovarian Cancer|Squamous Cell Carcinoma of the Head and Neck|Small Cell Lung Cancer|Renal Cell Carcinoma|RCC|Triple-negative Breast Cancer|Urothelial Carcinoma|Mismatch Repair Deficiency NCT Number: NCT03652077 Estimated Enrollment: 40 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study...
Read More
Condition: Advanced Cancer|Metastatic Cancer|Non-Hodgkin’s Lymphoma|Metastatic Breast Cancer|Malignant Mesothelioma|Non-small Cell Lung Cancer NCT Number: NCT01655225 Estimated Enrollment: 156 Phases: Phase 1 Age Group: 18 Years and older   (Adult, Older Adult) Gender: All Study Type: Interventional Study Results: No Results Available Study Design Allocation: Allocation: No Results Available Study ID Numbers: 13517|I6A-MC-CBBA Study First Received: August...
Read More
1 2 3
Call Now ButtonCALL NOW